The Enterprise Value as of December 2025 (TTM) for Genomics BioSci & Tech. Co.,Ltd. (4195.TWO) is 2.23B

According to Genomics BioSci & Tech. Co.,Ltd.’s latest financial reports and current stock price. The company's current Enterprise Value is 2.23B. This represents a change of 34.45% compared to the average of 1.66B of the last 4 quarters.

Genomics BioSci & Tech. Co.,Ltd. (4195.TWO) Historical Enterprise Value (quarterly & annually)

How has 4195.TWO Enterprise Value performed in the past?

The mean historical Enterprise Value of Genomics BioSci & Tech. Co.,Ltd. over the last ten years is 1.11B. The current 2.23B Enterprise Value has changed 20.12% with respect to the historical average. Over the past ten years (40 quarters), 4195.TWO's Enterprise Value was at its highest in in the June 2025 quarter at 1.84B. The Enterprise Value was at its lowest in in the June 2019 quarter at 0.

Genomics BioSci & Tech. Co.,Ltd. (4195.TWO) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of Genomics BioSci & Tech. Co.,Ltd. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Genomics BioSci & Tech. Co.,Ltd. (4195.TWO) Average Enterprise Value

How has 4195.TWO Enterprise Value performed in the past?

The current Enterprise Value of Genomics BioSci & Tech. Co.,Ltd. (4195.TWO) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

Genomics BioSci & Tech. Co.,Ltd. (4195.TWO) Enterprise Value vs. Peers

How is 4195.TWO’s Enterprise Value compared to its peers?

Genomics BioSci & Tech. Co.,Ltd.’s Enterprise Value is less than Sunny Pharmtech Inc. (2.41B), less than Chunghwa Chemical Synthesis & Biotech Co., Ltd. (2.50B), greater than Advagene Biopharma Co., Ltd. (1.69B), greater than Greenyn Biotechnology Co., Ltd (2.04B), greater than NaviFUS Corp. (1.27B), greater than Enimmune corporation (1.50B), less than Meribank Biotech Co., Ltd (2.56B), less than Hcmed (2.37B), greater than GeneReach Biotechnology Corp. (1.29B), less than GlycoNex Incorporation (2.43B),

Build a custom stock screener for Genomics BioSci & Tech. Co.,Ltd. (4195.TWO) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Genomics BioSci & Tech. Co.,Ltd. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Genomics BioSci & Tech. Co.,Ltd. (4195.TWO) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Genomics BioSci & Tech. Co.,Ltd. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.